Delivery Order SPE2DB25D9305-SPE2DB25FQACX

Award Date 2/24/25
Potential Completion Date 3/17/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $13,277.68 firm fixed-price delivery order is for the supply of a PHOTREXA CROSS-LINKING KIT 6ML product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a...
This federal contract award is for a delivery order valued at $9,855.93, awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of a pharmaceutical product called "PHOTREXA CROSS-LINKING KIT 6ML" to the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price delivery order with no set-aside designation. It is part of a larger indefinite delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $16,597.10 firm fixed-price delivery order contract is for the supply of Photrexa Cross-Linking Kits, a specialized pharmaceutical product. The contract is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This...
This federal contract award, valued at $26,555.36, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order (SPE2DB24FZC03) under DMS Pharmaceutical Group's existing indefinite delivery contract (SPE2DB22D9143) with DLA, which has a ceiling value of up to $499,999,999 and runs through December 31, 2025. The contract provides for the delivery of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,855.93 firm fixed-price delivery order is for the supply of a pharmaceutical product, specifically a "PHOTREXA CROSS-LINKING KIT 6ML." The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the...
This federal contract award, valued at $19,711.86, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order for the PHOTREXA CROSS-LINKING KIT 6ML product, which is a specialized medical supply. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $9,855.93, is a firm fixed-price delivery order for the supply of a PHOTREXA CROSS-LINKING KIT 6ML product. The contract is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC...
This federal contract award, valued at $3,727.51, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of Photrexa Cross-Linking Kits, a specialized pharmaceutical product. The contract is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the provision of a specialized pharmaceutical product, "PHOTREXA CROSS-LINKING KIT 6ML," with a ceiling value of $19,916.52 and a completion date of November 20, 2024. The contract is a firm fixed-price delivery order and is not associated with any...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $79,666.08 firm fixed-price Delivery Order contract is for the provision of a medical product, specifically the "PHOTREXA CROSS-LINKING KIT 6ML." This contract award is associated with a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that the DLA has awarded to DMS...
  • SPE2DB25D9305
    Indefinite Delivery Contract
  • SPE2DB25D9305-SPE2DB25FQACX
    Delivery Order

This federal contract award, valued at $14,910.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the procurement of "PHOTREXA CROSS-LINKING KIT 6ML", a specialized pharmaceutical product.

The award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains.

Generated 6/1/25, 3:34 AM